Balancing Favourable Drug-Likeness Against Respiratory and Renal Liabilities: An Integrated In Silico ADME–Toxicity Profile of a Novel 3-{[2-(Formimidoylamino)ethyl]sulfanyl}-6-(1-methoxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carbonyl fluoride. Editon Cons. j. res. med. health sci. 2026;6(1):28-40. doi:10.51317/ecjrmhs.v6i1.758